Search research articles
Contact Us
Filters
Showing results (211-220 of 216) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 216 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma
Raquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Cancer Discovery
|
June 10, 2018
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Tao Wang, Rong Lu, Payal Kapur, et al.
Cancer Discovery
|
October 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Junhua Lyu, Yuxuan Liu, Lihu Gong, et al.
Immunity
|
February 10, 2019
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
Chien-Chun Steven Pai, John T Huang, Xiaoqing Lu, et al.
Journal of Hematology & Oncology
|
October 24, 2025
HCB101: a novel potent ligand-trap Fc-fusion protein targeting the CD47-SIRPα pathway with high safety and preclinical efficacy for hematological and solid tumors
Jiin-Tarng Wang, Chi-Ling Tseng, Han-Fang Teng, et al.
Science Translational Medicine
|
November 26, 2020
Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation
Lam T Khuat, Catherine T Le, Chien-Chun Steven Pai, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 216) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 216 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma
Raquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Cancer Discovery
|
June 10, 2018
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Tao Wang, Rong Lu, Payal Kapur, et al.
Cancer Discovery
|
October 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Junhua Lyu, Yuxuan Liu, Lihu Gong, et al.
Immunity
|
February 10, 2019
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
Chien-Chun Steven Pai, John T Huang, Xiaoqing Lu, et al.
Journal of Hematology & Oncology
|
October 24, 2025
HCB101: a novel potent ligand-trap Fc-fusion protein targeting the CD47-SIRPα pathway with high safety and preclinical efficacy for hematological and solid tumors
Jiin-Tarng Wang, Chi-Ling Tseng, Han-Fang Teng, et al.
Science Translational Medicine
|
November 26, 2020
Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation
Lam T Khuat, Catherine T Le, Chien-Chun Steven Pai, et al.
Page
of 22